Janus Henderson Horizon Biotechnology Fund A2 EUR/  LU2441282899  /

Fonds
NAV17/05/2024 Chg.+0.0900 Type de rendement Focus sur l'investissement Société de fonds
20.7600EUR +0.44% reinvestment Equity Worldwide Janus Henderson Inv. 

Stratégie d'investissement

The Fund aims to provide capital growth over the long term. The Fund invests at least 80% of its assets in shares (equities) and equity-related securities of companies, which are biotechnology or biotechnology-related, of any size, including smaller capitalisation companies, in any country. The Fund may also invest in other assets including bonds (including convertible bonds), preference shares, cash and money market instruments. The Investment Manager may use derivatives (complex financial instruments) with the aim of making investment gains in line with the Fund's objective, to reduce risk or to manage the Fund more efficiently.
 

Objectif d'investissement

The Fund aims to provide capital growth over the long term.
 

Opérations

Type de rendement: reinvestment
Fonds Catégorie: Equity
Région de placement: Worldwide
Branche: Sector Biotechnology
Benchmark: NASDAQ Biotechnology Total Return Index
Début de l'exercice: 01/07
Dernière distribution: -
Banque dépositaire: BNP Paribas Securities Services, Niederlassung Luxemburg
Domicile: Luxembourg
Permission de distribution: Austria, Germany, Switzerland
Gestionnaire du fonds: Andy Acker, Daniel Lyons, Agustin Mohedas
Actif net: 261.8 Mio.  USD
Date de lancement: 25/02/2022
Focus de l'investissement: -

Conditions

Surtaxe d'émission: 5.00%
Frais d'administration max.: 1.20%
Investissement minimum: 2,500.00 EUR
Deposit fees: 0.65%
Frais de rachat: 1.00%
Prospectus simplifié: -
 

Société de fonds

Société de fonds: Janus Henderson Inv.
Adresse: 201 Bishopsgate, EC2M 3AE, London
Pays: United Kingdom
Internet: www.janushenderson.com/
 

Actifs

Stocks
 
97.70%
Bonds
 
1.93%
Cash
 
0.37%

Pays

United States of America
 
67.71%
United Kingdom
 
5.07%
Netherlands
 
4.51%
Ireland
 
3.88%
Denmark
 
2.69%
France
 
2.44%
Virgin Islands (British)
 
2.15%
China
 
1.80%
Cayman Islands
 
1.16%
Canada
 
0.67%
Cash
 
0.37%
Autres
 
7.55%

Branches

Pharma/Biotechnology
 
87.89%
Healthcare services
 
1.52%
Healthcare appliances
 
0.75%
Cash
 
0.37%
Autres
 
9.47%